Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02354586
Title A Study of Niraparib in Patients With Ovarian Cancer Who Have Received at Least Three Previous Chemotherapy Regimens
Recruitment Active, not recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Tesaro, Inc.
Indications

peritoneal serous adenocarcinoma

fallopian tube serous adenocarcinoma

ovary serous adenocarcinoma

Therapies

Niraparib

Age Groups: adult
Covered Countries USA | CAN


No variant requirements are available.